Novo Seven 1mg (Eptacog Alfa (Activated ) Vials) 1mg

Novo Seven 1mg contains Eptacog Alfa (Activated), a coagulation factor VIIa used to control bleeding in hemophilia patients. This 1mg vial form supports prompt hemostasis when administered as directed. Store between 15-25°C to maintain potency. Ideal for emergency bleeding management.

Strength

1mg

Pack Size

Storage

15-25°

Manufacturer / TM Owner

Novo Nordisk A/S

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Novo Seven 1mg is used to treat and prevent bleeding episodes in patients with hemophilia A or B who have inhibitors. It may also be used for acquired hemophilia or congenital factor VII deficiency. This medication helps promote blood clotting when natural mechanisms are impaired. It is intended for use under medical supervision during active bleeding or surgical procedures.

Side Effects

After administration, Novo Seven 1mg works by binding to tissue factor at the injury site to initiate the clotting process. Users may notice reduced bleeding or faster clot formation following treatment. Some individuals report temporary warmth or redness at the injection site. Effects vary based on the underlying condition and response.

Precautions & Warnings

Novo Seven 1mg should be handled with care to avoid contamination or improper storage. Keep the vial in its original packaging until ready to use. Do not freeze or expose to extreme temperatures. Always check the solution for particles or discoloration before administration. Discard any unused portion after use.

Avoid Interactions

Concomitant use with other hemostatic agents may increase the risk of clotting complications. Antifibrinolytic agents like tranexamic acid may be used cautiously under medical guidance. Avoid mixing with other medications in the same syringe. Consult healthcare providers about potential interactions with blood products or anticoagulants.

Frequently Asked Questions

Novo Seven 1mg is used to treat bleeding episodes in hemophilia patients with inhibitors.

Store between 15-25°C and protect from light. Do not freeze or refrigerate.

Yes, it may be used before or during surgery to prevent excessive bleeding in hemophilia patients.

Common effects include injection site reactions like redness or warmth.

No, Novo Seven 1mg requires a prescription for safe and proper use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.